Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
QURE
#2145
uniQure N.V.
15.6
3
-9.76%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-9.76%
Mudança mensal
-34.90%
Mudança em 6 meses
-1.01%
Mudança anual
+33.02%
Fechamento anterior
17.3
2
Open
15.6
3
Bid
Ask
Low
15.6
3
High
15.6
3
Volume
137
Mercados
Ações
Cuidados de saúde
QURE
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
44.99 M
46.46 M
46.98 M
47.84 M
54.08 M
—
Valuation ratios
Enterprise value
1.38 B
407.26 M
798.09 M
90.16 M
796.07 M
4.71 B
Price to earnings ratio
—
2.95
-8.06
-1.07
-3.59
-22.97
Price to sales ratio
—
1.85
9.59
20.85
31.68
304.34
Price to cash flow ratio
—
3.37
7.04
2.26
4.7
31.94
Price to book ratio
—
1.63
2.14
1.59
127.24
149.22
Enterprise value to EBITDA ratio
-8.26
1.64
-4.11
-0.28
54.59
-31.41
Profitability ratios
Return on assets %
0.37
0.41
0.18
0.37
0.43
0.05
Return on equity %
0.51
0.55
0.27
1.49
35.48
2.37
Return on invested capital %
-537.78
796.56
-212.61
-426.75
-377.81
-373.73
Gross margin %
92.27
95.23
98.82
99.59
95.33
352.35
Operating margin %
-334.34
59.28
-134.44
-1 785.46
-679.58
-5 600.29
EBITDA margin %
-445.82
47.52
-182.45
-2 064.32
53.77
-1 009.24
Net margin %
333.27
62.9
119.07
1 947.09
883.35
1 295.26
Liquidity ratios
Quick ratio
—
—
6.19
8.68
—
—
Current ratio
9.47
17.09
6.28
8.85
9.74
38.84
Inventory turnover
—
—
0.18
0.01
—
—
Asset turnover
0.1
0.91
0.14
0.02
0.04
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.1
0.12
0.15
0.12
0.09
0.32
Long term debt to total equity ratio
0.15
0.17
0.22
0.49
-7.6
-18.79
Per share metrics
Operating cash flow per share
—
6.15
-3.1
-3.06
-3.76
-2.94
EBIT per share
—
5.19
-4.33
-7.31
-0.13
-1.09
EBITDA per share
—
5.32
-4.16
-6.86
0.3
-0.93
Total debt per share
—
—
—
—
—
—
Cash per share
—
11.88
7.55
12.96
7.56
34.6
Net current asset value per share
—
13.41
10.2
13.67
8.02
36.53
Tangible book value per share
—
10.79
8.38
2.53
-2.06
-1.69
Working capital per share
—
12.63
8.58
12.13
7.2
32.47
Book value per share
—
12.72
10.19
4.36
-0.14
4.52
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
Notícias
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)
uniQure divulga resultados com destino regulatório do AMT-130 em foco
uniQure earnings in focus as AMT-130 regulatory path looms
Stifel comenta ações da uniQure após declarações do comissário da FDA
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Applied Materials, Broadcom among market cap stock movers on Thursday
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Ações da UniQure despencam após comentários do FDA sobre teste de terapia genética
UniQure stock tumbles on FDA comments about gene therapy trial
Wolfe Research inicia cobertura da uniQure com classificação Peerperform
uniQure stock initiated at Peerperform by Wolfe Research